TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00133887
Recruitment Status : Completed
First Posted : August 24, 2005
Last Update Posted : July 2, 2014
Information provided by (Responsible Party):
Hospices Civils de Lyon